175 related articles for article (PubMed ID: 10049443)
21. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Claydon PE; Ackroyd R
Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
[TBL] [Abstract][Full Text] [Related]
22. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Wolfsen HC
J Clin Gastroenterol; 2005 Mar; 39(3):189-202. PubMed ID: 15718860
[TBL] [Abstract][Full Text] [Related]
23. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus.
Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Stoddard CJ; Reed MW
Dis Esophagus; 2000; 13(1):18-22. PubMed ID: 11005326
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients.
Weiss AA; Wiesinger HA; Owen D
Can J Gastroenterol; 2006 Apr; 20(4):261-4. PubMed ID: 16609754
[TBL] [Abstract][Full Text] [Related]
25. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.
Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY
Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for gastrointestinal disease.
Petersen BT; Chuttani R; Croffie J; DiSario J; Liu J; Mishkin D; Shah R; Somogyi L; Tierney W; Wong Kee Song LM
Gastrointest Endosc; 2006 Jun; 63(7):927-32. PubMed ID: 16733105
[No Abstract] [Full Text] [Related]
28. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus.
Overholt B; Panjehpour M; Tefftellar E; Rose M
Gastrointest Endosc; 1993; 39(1):73-6. PubMed ID: 8454152
[No Abstract] [Full Text] [Related]
29. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy in Barrett's esophagus.
Overholt BF; Panjehpour M
J Clin Laser Med Surg; 1996 Oct; 14(5):245-9. PubMed ID: 9612190
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M;
Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
36. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.
Hage M; Siersema PD; van Dekken H; Steyerberg EW; Haringsma J; van de Vrie W; Grool TE; van Veen RL; Sterenborg HJ; Kuipers EJ
Gut; 2004 Jun; 53(6):785-90. PubMed ID: 15138203
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus.
Wolfsen HC
Dig Dis; 2002; 20(1):5-17. PubMed ID: 12145415
[TBL] [Abstract][Full Text] [Related]
38. Photofrin to treat precancerous lesions in Barrett's esophagus.
FDA Consum; 2003; 37(6):4. PubMed ID: 14983805
[No Abstract] [Full Text] [Related]
39. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
[TBL] [Abstract][Full Text] [Related]
40. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
